Skip to main content

Day: February 1, 2022

Luxury Goods Market Size to Hit $352.84 Billion by 2027 | Luxury Goods Industry Trends, Growth Rate, Analysis and Forecast Report by Fortune Business Insights

Companies covered in Luxury Goods Market are LVMH Moët Hennessy-Louis Vuitton SA (Paris, France), Compagnie Financière Richemont SA (Geneva, Switzerland), Kering SA (Paris, France), Chow Tai Fook Jewellery Group Limited (Central, Hong Kong), The Estée Lauder Companies Inc. (New York, U.S.), Luxottica Group SpA (Milan, Italy) The Swatch Group Ltd. (Biel / Bienne, Switzerland), L’Oréal Group (Clichy, France), Ralph Lauren Corporation (New York, U.S.), Shiseido Company, Limited (Tokyo, Japan), and more players profiled Pune, India, Feb. 01, 2022 (GLOBE NEWSWIRE) — The worldwide luxury goods market is projected to grow from USD 257.26 billion in 2020 to USD 352.84 billion in 2027 at a CAGR of 4.6% in the forecast period.  Luxury goods are mainly purchased by the high-income group across the globe. Oxfam International’s data, for instance,...

Continue reading

SFIO Appoints Experts Across F&B, Real Estate, and Technology onto Advisory Board

NEW YORK, Feb. 01, 2022 (GLOBE NEWSWIRE) — Starfleet Innotech, Inc. (OTCPink: SFIO), a leading asset management company and innovation group, is pleased to share details around the advisory board it has assembled to lead its global expansion plans across its core divisions. Dear shareholders and valued business partners, I am pleased to finally be addressing you all on behalf of Starfleet Innotech, Inc., following the formalization of our new company name. Our friends in the media have already begun updating their databases to reflect this change, so expect to be seeing more of Starfleet across your feeds as we mobilize our communication efforts around our roadmap for 2022. In my last address, I shared a comprehensive look at our strategy towards uplisting to the Nasdaq within the next three years. This strategy revolves around...

Continue reading

BioCryst to Present New ORLADEYO® (berotralstat) Data at 2022 American Academy of Allergy, Asthma & Immunology Annual Meeting

RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present three abstracts featuring new data on oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, which is being held live in Phoenix, Arizona, and virtually, from February 25-28, 2022. “The long-term data from our APeX-2 pivotal trial continues to demonstrate that ORLADEYO delivers sustained reductions in attack rates and improvement in quality of life among patients living with HAE,” said Dr. William Sheridan, chief medical officer of BioCryst. “These insights highlight the value ORLADEYO provides to the HAE community as an oral, once-daily prophylactic...

Continue reading

ACNB Insurance Services, Inc. Acquires Leading Agency in Gettysburg, PA

ACNB Insurance Services, Inc.ACNB Insurance Services, Inc. Acquires Leading Agency in Gettysburg, PAGETTYSBURG, Pa., Feb. 01, 2022 (GLOBE NEWSWIRE) — ACNB Corporation (NASDAQ: ACNB), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced today that its wholly-owned subsidiary, ACNB Insurance Services, Inc., has entered into an agreement to acquire the business and assets of Hockley & O’Donnell Insurance Agency LLC, Gettysburg, PA. “We are very pleased to have entered into this agreement and look forward to promptly closing this transaction. Hockley & O’Donnell is a leading insurance agency in our home market of Gettysburg,” said James P. Helt, ACNB Corporation and ACNB Bank President & Chief Executive Officer. “This long-established agency brings an outstanding team...

Continue reading

EzFill Announces New Fleet Agreement with Floridian Clinical Research

Leading Florida-Based Mobile Fueling Company to Regularly Service the Research Facility’s Fleet of Vehicles MIAMI, FL, Feb. 01, 2022 (GLOBE NEWSWIRE) — EzFill Holdings, Inc. (“EzFill” or the “Company”) (NASDAQ: EZFL), a pioneer and emerging leader in the on-demand mobile fuel industry, announced today the signing of a new fleet agreement with Floridian Clinical Research in Miami Lakes, Florida. EzFill, one of the largest on-demand mobile fuel delivery providers in the state of Florida, will regularly service the leading clinical research facility’s fleet of delivery and transport vehicles. “With this agreement, we are proud to add the medical and research community to the growing list of industries we serve throughout the Miami area,” said Mike McConnell, CEO of EzFill. “Our mobile fuel delivery service enables Floridian’s drivers...

Continue reading

Surna Cultivation Technologies Announces Leandru Schiau as New Product Manager

Growth Strategy Execution at Heart of New Hire Louisville, Colorado, Feb. 01, 2022 (GLOBE NEWSWIRE) — Surna Cultivation Technologies LLC, a leader in controlled environment agriculture (CEA) systems engineering and technologies and a subsidiary of CEA Industries Inc. (OTCQB: CEAD), hired Leandru Schiau as Product Manager. Mr. Schiau brings over a decade of experience building and leading product development for several global organizations. “Surna Cultivation Technologies has been introducing new products and services at a breakneck speed as we aggressively execute on our strategic plan announced last year,” said Jamie English, Vice President of Marketing. “To continue delivering on our growth strategy, we are thrilled to have a seasoned product development manager such as Leandru join us. With Mr. Schiau on staff, we are confident...

Continue reading

Qualigen Therapeutics Engages Professor Stephen Neidle as Scientific Advisor in the Development of Lead Program QN-302

Innovator Behind Pancreatic Cancer-Focused Program Becomes Scientific Advisor CARLSBAD, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, today announced that it has engaged Professor Stephen Neidle as a scientific advisor. Professor Neidle is a world-renowned scientist at University College London and is the key innovator of the Company’s in-licensed genomic quadruplex (G4)-selective transcription inhibitor platform. Qualigen is developing this platform’s lead compound, now called QN-302, as a potential treatment for pancreatic ductal adenocarcinoma (PDAC), which represents the vast majority of pancreatic cancers. “Professor Neidle’s extensive knowledge in the development...

Continue reading

Aurcana Announces Non-Brokered Private Placement of Up to C$6 Million in Units and Closing of First Tranche for $5.298 Million

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 01, 2022 (GLOBE NEWSWIRE) — AURCANA SILVER CORPORATION (“Aurcana” or the “Company“) (TSXV: AUN) is pleased to announce a non-brokered private placement offering (the “Private Placement”) of up to C$6 Million, consisting of up to 17,142,857 Units at a price of C$0.35 per Unit (the “Units”), subject to the approval of the TSX Venture Exchange. The Company has closed the first tranche of 15,138,071 units for a total of $5,298,325. The second tranche will be closing in the near future. Each Unit will consist of one common share of the Company and one full common share purchase warrant (“Warrant”), with each Warrant entitling the holder thereof to purchase one common share at a price of C0.525...

Continue reading

PJET and ALYI Announce Electric Motorcycles And Scooters For College Campuses

Dallas, Texas, Feb. 01, 2022 (GLOBE NEWSWIRE) — Priority Aviation, Inc. (OTC Pink: PJET) (“PJET”) and Alternet Systems, Inc. (OTC Pink: ALYI) (“ALYI”) today announced the companies have finalized production plans for the electric motorcycles and scooters to be produced by Alternet Systems, Inc. (OTC Pink: ALYI) for use on university campuses.  The first shipment is expected to soon be in route to the U.S. to support PJET’s university campus roadshow starting in Texas later in the first quarter where the electric motorcycle and scooter models will be demonstrated, and orders taken. The electric motorcycle and scooter offering is part of PJET’s overall plan to build a branded suite of services for an estimated 500 million college students worldwide today, and their college bound children tomorrow. PJET recently published the company’s...

Continue reading

Sintana Announces $10 Million Marketed Public Offering of Units

NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 01, 2022 (GLOBE NEWSWIRE) — Sintana Energy Inc. (TSXV: SEI) (the “Sintana” or “Company“) is pleased to announce that further to its press release dated January 20, 2022, it has filed a preliminary short form prospectus with the securities commissions or similar regulatory authorities in each of the provinces of Canada, other than Quebec (the “Canadian Jurisdictions”), in connection with a marketed public offering (the “Offering”) of units (the “Units”) of the Company, at a price of $0.15 per Unit, for gross proceeds of a minimum of $7,000,000 and a maximum of $10,000,000 (subject to increase pursuant to an over-allotment option to raise up to an additional $1,500,000). The preliminary short form prospectus is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.